Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mrfox
    Senior Member
    • Aug 2010
    • 103

    #1

    Germine copy number variation detection?

    Hi all,
    I have the normal tissue of about 20 cancer patients with family cancer history. We would like to perform exome sequencing to identify germline mutations, especially germline copy number variations but have not much experience. A couple of questions:

    1) What will be a good "reference"/normal BAM file? Randomly selecting reads from BAM files of some normal people sequencing data?
    2) Assume we have such a BAM files in 1), can we just use public software tools such as VarScan2 to compare the patient's BAM with the reference BAM?

    Any input is greatly appreciated!
  • etal
    Member
    • Oct 2013
    • 23

    #2
    Originally posted by mrfox View Post
    1) What will be a good "reference"/normal BAM file? Randomly selecting reads from BAM files of some normal people sequencing data?
    You can use a program like CoNIFER or cn.MOPS to process the samples as a cohort. These programs each use a statistical method to consider all of the given samples in aggregate to determine the "expected" baseline for copy number inference.

    Alternatively, CNVkit works more like your proposal, where a reference copy number profile is initially constructed from a pool of normal BAM files and then reused to infer CNVs in individual samples. CNVkit can also operate without any normal-sample reference at all, but results will be slightly noisier.

    Originally posted by mrfox View Post
    2) Assume we have such a BAM files in 1), can we just use public software tools such as VarScan2 to compare the patient's BAM with the reference BAM?
    Yes, you could. Be careful to check that any recurrent CNVs you find aren't simply the result of having a region of unusually high or low read depth in your reference BAM.

    Most program for copy number inference will give you some indication of how the reference should be built and whether you should process one sample at a time or the whole cohort at once.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...